Legal Opinion
In Re Terazosin Hydrochloride Antitrust Litigation
District Court, S.D. Florida
Decided July 25, 2001No. 99-MDL-1317PublishedCited by 28 opinions
1Opinion of the Court
ORDER GRANTING DEFENDANTS’ MOTION TO DISMISS CERTAIN COUNTS OF THE INDIRECT PURCHASER PLAINTIFFS’ COMPLAINT
SEITZ, District Judge.
Defendants Abbott Laboratories [“Abbott”], Geneva Pharmaceuticals, Inc. [“Geneva”], and Zenith Goldline Pharmaceuticals, Inc. [“Zenith”] have moved to dismiss federal and state antitrust or unjust enrichment claims raised by “indirect purchasers” — individuals, corporations, and employee health plans that purchased prescription drugs containing terazosin hydrochloride after October 15, 1995, for consumption or redistribution' instead of resale. (Defs.’ Mot., Oct. 6,…
2Cases cited41 opinions
- Warth v. SeldinSupreme Court of the United States · 1975
- Larry Bonner v. City of Prichard, AlabamaCourt of Appeals for the Eleventh Circuit · 1981
- Lewis v. CaseySupreme Court of the United States · 1996
- Associated General Contractors of California, Inc. v. California State Council of CarpentersSupreme Court of the United States · 1983
- Zenith Radio Corp. v. Hazeltine Research, Inc.Supreme Court of the United States · 1969
36 more not listed; retrieve them via the Exa API.
3Cited by28 opinions
- Freeman Industries, LLC v. Eastman Chemical Co.Tennessee Supreme Court · 2005
- Johnson v. Microsoft Corp.Ohio Supreme Court · 2005
- In Re Dynamic Random Access Memory (DRAM) Antitrust LitigationDistrict Court, N.D. California · 2007
- In Re Graphics Processing Units Antitrust LitigationDistrict Court, N.D. California · 2007
- In Re New Motor Vehicles Canadian Export Antitrust LitigationDistrict Court, D. Maine · 2004
23 more not listed; retrieve them via the Exa API.